Last reviewed · How we verify
NCT06790849
ETASCAI Pilot Project
NA trial testing Active 1 ETAS® in Cognition in 45 participants. Completed in 22 October 2025.
22 October 2025
Quick facts
| Lead sponsor | University of Reading |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 45 |
| Start date | 24 February 2025 |
| Primary completion | 22 October 2025 |
| Estimated completion | 22 October 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Active 1 ETAS®
- Active 2 ETAS®
- Placebo
Conditions studied
- Cognition — all drugs for Cognition →
- Affect (Mental Function) — all drugs for Affect (Mental Function) →
- Inflammation — all drugs for Inflammation →
Sponsor
University of Reading
Who can join
Adults 60 to 80, any sex, with Cognition or Affect (Mental Function). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study aims to investigate the chronic effects of ETAS® on cognitive, affective and inflammatory outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06790849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognition
Currently open trials in the same condition.
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07109505 — Nutrition to Support Postoperative Recovery · NA · recruiting
- NCT07334392 — Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairm · NA · recruiting
- NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
- NCT07231497 — Cognitive Strategies in Early Psychosis 1 · Phase 3 · recruiting
Other University of Reading trials
Trials by the same sponsor.
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07006909 — Hair Isotope Analysis for Early Cancer Detection · not yet recruiting
- NCT06832488 — Food Texture, Eating Rate and Food Intake in Care Home Older Adults. · NA · completed
- NCT07056634 — The Effects of Nature-Based Activity vs. Indoor Exercise on Cognition, Psychological, and Physiological Health · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06790849 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Reading
- Last refreshed: 19 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06790849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing